Dublin, Feb. 10, 2020 (GLOBE NEWSWIRE) -- The "Apheresis Market by Product [Device (Centrifugation, Membrane Separation) Disposable], Procedure (Donor, Therapeutic ...
DUBLIN--(BUSINESS WIRE)--The "Apheresis Equipment - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. The report provides separate comprehensive ...
May 23 (UPI) --A new treatment might be able to remove "bad cholesterol" from the blood in a matter of hours, a recent study says. Within two to three hours, a procedure known as LDL apheresis drove ...
Significant advances have been made over the last 20 years in long-term immunomodulatory therapy of multiple sclerosis. However, the same cannot be said for the treatment of acute relapses, explain ...
The growth of the therapeutic apheresis market is driven by rise in prevalence of chronic and autoimmune diseases, technological advancements in apheresis devices, and favorable government initiatives ...
ENGLEWOOD, Colo., Aug. 15, 2022 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Apheresis for Leukemia and Pediatric Patients. Emerging Economies With Increasing Investments From Government Bodies and Leading Players. This study involved the extensive use of both primary and ...
(MENAFN- EIN Presswire) EINPresswire/ -- The global therapeutic apheresis market is projected to grow from US$3.2 billion in 2026 to US$3.9 billion by 2033, at a CAGR of 2.7%. Therapeutic apheresis ...
Rising Prevalence of Chronic Diseases and Growing Number of Trauma and Injury Cases. Increasing Demand for Source Plasma From Biopharmaceutical Companies. Rising Demand for Blood Components and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results